Single Shot Liposomal Bupivicaine in Rotator Cuff Surgery
Status:
Completed
Trial end date:
2020-01-22
Target enrollment:
Participant gender:
Summary
This document is a protocol for a human research study. This study is to be conducted
according to United States standards of Good Clinical Practice in accordance with applicable
Federal regulations and institutional research policies and procedures.
Liposomal bupivacaine (LB) has been shown to decrease post-operative pain and narcotic use
when administered perioperatively as a local injection during arthroplasty procedures.
Studies have also demonstrated that LB used in conjunction with dexamethasone may increase
the duration of effectiveness of LB. This study seeks to evaluate if there is a difference in
post-operative pain and narcotic use when LB is administered in an interscalene block during
outpatient rotator cuff repair surgery. Furthermore, this study aims to determine if the
addition of dexamethasone with LB results in a prolonged decrease in post-operative pain and
a reduction in narcotic use.